Multidrug-resistant Gram-negative bacteria: Difference between revisions

Revision as of 10:18, 26 August 2020

Ceftolozane-tazobactam (Zerbaxa)
- May be better for multidrug-resistance Pseudomonas (or at least more experience with it)
Ceftazidime-avibactam: available through Special Access Program
- Adds coverage of some carbapenemases and AmpC
Fosfomycin
Colistin
Cefiderocol: available through Special Access Program as well as preapproval by manufacturer
Meropenem-vaborbactam: still awaiting Health Canada Drug Review
Imipenem-relebactam (really imipenem-cilastatin-relebactam): still awaiting Health Canada Drug Review

Revision as of 09:31, 26 August 2020 (view source) Aidan (talk \| contribs) (→�) Tag: Visual edit ← Older edit	Revision as of 10:18, 26 August 2020 (view source) Aidan (talk \| contribs) m (Aidan moved page Multidrug resistance Gram-negative bacteria to Multidrug-resistant Gram-negative bacteria without leaving a redirect) Newer edit →
(No difference)